» Articles » PMID: 10675086

Mitochondrial Respiratory Chain Disorders I: Mitochondrial DNA Defects

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 2000 Feb 16
PMID 10675086
Citations 73
Authors
Affiliations
Soon will be listed here.
Abstract

Mitochondria have a pivotal role in cell metabolism, being the major site of ATP production via oxidative phosphorylation (OXPHOS); they have a critical role in apoptotic cell death; and they also contribute to human genetics since mitochondria have a functional genome separate from that of nuclear DNA. Defects of mitochondrial metabolism are associated with a wide spectrum of disease. An Important part of this spectrum is caused by mutations of mitochondrial DNA (mtDNA). These class I OXPHOS diseases are covered in part I of this two-part review. Dysfunction of mitochondrial OXPHOS has also emerged as an important component of a range of predominantly neurodegenerative diseases in which the mitochondrial abnormality is most probably secondary. These class II OXPHOS diseases are due to mutations of genes not encoding OXPHOS subunits or are caused by exogenous or endogenous OXPHOS toxins. Class II mitochondrial diseases and the mitochondrion's role in apoptosis are covered in part II (Lancet 2000; 355: 389-94).

Citing Articles

Phenotypic diversity in NAXE mutations.

Solmaz I, Yalnizoglu D, Dursun A, Ciki K, Akar H, Koksal Ozgul R Neurol Sci. 2025; .

PMID: 39937421 DOI: 10.1007/s10072-025-08006-z.


Comprehensive review of mitochondrial nephropathy-a renal phenotype in mitochondrial disease: causative genes, clinical and pathological features, diagnosis, prognosis, and treatment.

Imasawa T, Murayama K, Hirano D, Nozu K Clin Exp Nephrol. 2024; 29(1):39-56.

PMID: 39625678 DOI: 10.1007/s10157-024-02554-y.


Case report: Late-onset MELAS syndrome with mtDNA 5783G>A mutation diagnosed by urinary sediment genetic testing.

Cai H, Li L, Zhang M, Zhou Y, Li P Front Genet. 2024; 15:1367716.

PMID: 38881794 PMC: 11176442. DOI: 10.3389/fgene.2024.1367716.


Advancing the neuroimaging diagnosis and understanding of mitochondrial disorders.

Alves C, Whitehead M Neurotherapeutics. 2024; 21(1):e00324.

PMID: 38306952 PMC: 10903090. DOI: 10.1016/j.neurot.2024.e00324.


APE1 regulates mitochondrial DNA damage repair after experimental subarachnoid haemorrhage in vivo and in vitro.

Dai K, Wang Z, Gao B, Li L, Gu F, Tao X Stroke Vasc Neurol. 2023; 9(3):230-242.

PMID: 37612054 PMC: 11221324. DOI: 10.1136/svn-2023-002524.